These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2360254)

  • 1. Evidence that drug-resistant alloreactive T cells may contribute to human graft rejection.
    Stanford WL; Strauss GH; Finn OJ
    Transplantation; 1990 Jun; 49(6):1138-41. PubMed ID: 2360254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys).
    Zimmer DM; Aaron CS; O'Neill JP; Albertini RJ
    Environ Mol Mutagen; 1991; 18(3):161-7. PubMed ID: 1915311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
    Dayton JS; Turka LA; Thompson CB; Mitchell BS
    Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine associated T-cell mutations in insulin-dependent diabetes mellitus.
    Falta MT; Atkinson MA; Allegretta M; Vacek PM; Albertini RJ
    Scand J Immunol; 2000 Jun; 51(6):626-33. PubMed ID: 10849375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.
    Thomas CW; Myhre GM; Tschumper R; Sreekumar R; Jelinek D; McKean DJ; Lipsky JJ; Sandborn WJ; Egan LJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):537-45. PubMed ID: 15388785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular target of cyclosporin A action in humans.
    Van Buren CT; Kerman R; Agostino G; Payne W; Flechner S; Kahan BD
    Surgery; 1982 Aug; 92(2):167-74. PubMed ID: 6213052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of transplant rejection: current treatment guidelines and future developments.
    Perico N; Remuzzi G
    Drugs; 1997 Oct; 54(4):533-70. PubMed ID: 9339960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of immunosuppressive drugs on human T, B, and K lymphocytes.
    Thomas F; Thomas J; Mendez G; Lower R; Lee HM
    Transplantation; 1977 Dec; 24(6):435-41. PubMed ID: 339440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy].
    Bullinger W; Hammer C; Land W; Welter H
    Chir Forum Exp Klin Forsch; 1979; ():319-24. PubMed ID: 378592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copolymer 1 inhibits manifestations of graft rejection.
    Aharoni R; Teitelbaum D; Arnon R; Sela M
    Transplantation; 2001 Aug; 72(4):598-605. PubMed ID: 11544417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo.
    Strauss GH; Albertini RJ
    Mutat Res; 1979 Jul; 61(2):353-79. PubMed ID: 384224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes.
    Jones IM; Burkhart-Schultz K; Carrano AV
    Mutat Res; 1985 Jun; 147(3):97-105. PubMed ID: 3873611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells.
    Lennard L; Maddocks JL
    J Pharm Pharmacol; 1983 Jan; 35(1):15-8. PubMed ID: 6131958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans.
    O'Neill JP; McGinniss MJ; Berman JK; Sullivan LM; Nicklas JA; Albertini RJ
    Mutagenesis; 1987 Mar; 2(2):87-94. PubMed ID: 3331707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.
    Oancea I; Movva R; Das I; Aguirre de Cárcer D; Schreiber V; Yang Y; Purdon A; Harrington B; Proctor M; Wang R; Sheng Y; Lobb M; Lourie R; Ó Cuív P; Duley JA; Begun J; Florin TH
    Gut; 2017 Jan; 66(1):59-69. PubMed ID: 27411368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of azathioprine on in vitro antibody response. Differential effect on B cells involved in thymus-dependent and independent responses.
    Galanaud P; Crevon MC; Dormont J
    Clin Exp Immunol; 1975 Oct; 22(1):139-52. PubMed ID: 1082392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enumeration of thioguanine-resistant lymphocytes using autoradiography.
    Morley AA; Cox S; Wigmore D; Seshadri R; Dempsey JL
    Mutat Res; 1982 Aug; 95(2-3):363-75. PubMed ID: 7121491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Langman LJ; LeGatt DF
    Transplant Proc; 1996 Dec; 28(6):3013-5. PubMed ID: 8962169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.